⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PEN News
Penumbra, Inc.
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
PEN
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
PEN
Semi-Trailer Dealership Market Set to Reach US$ 17.7 Billion by 2035 | Astute Analytica
globenewswire.com
WNC
GNE
PEN
UHAL
WMT
R
Embolotherapy Strategy Insights and Market Forecast to 2033 - Healthcare Facilities Under Pressure to Adopt Next-Gen Embolotherapy for Better Outcomes - ResearchAndMarkets.com
businesswire.com
PEN
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
prnewswire.com
PEN
Penumbra, Inc. Reports Third Quarter 2025 Financial Results
prnewswire.com
PEN
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
prnewswire.com
PEN
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
prnewswire.com
PEN
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
prnewswire.com
PEN
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
prnewswire.com
PEN